These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 19133681)

  • 1. Sudden cardiac death complicating alcohol septal ablation: a case report and review of literature.
    Antoun P; El Masry H; Breall JA
    Catheter Cardiovasc Interv; 2009 Jun; 73(7):956-9. PubMed ID: 19133681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The problem of orphan procedures: Comment on "sudden cardiac death complicating alcohol septal ablation: a case report and review of literature".
    Tobis J
    Catheter Cardiovasc Interv; 2009 Jun; 73(7):960. PubMed ID: 19455562
    [No Abstract]   [Full Text] [Related]  

  • 3. Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: is it safe?
    Veselka J
    Catheter Cardiovasc Interv; 2009 Sep; 74(3):520-1; author reply 522. PubMed ID: 19496117
    [No Abstract]   [Full Text] [Related]  

  • 4. Ventricular arrhythmia following alcohol septal ablation for obstructive hypertrophic cardiomyopathy.
    Noseworthy PA; Rosenberg MA; Fifer MA; Palacios IF; Lowry PA; Ruskin JN; Sanborn DM; Picard MH; Vlahakes GJ; Mela T; Das S
    Am J Cardiol; 2009 Jul; 104(1):128-32. PubMed ID: 19576333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sudden death after alcohol septal ablation in hypertrophic cardiomyopathy.
    Efthimiadis GK; Pagourelias ED; Meditskou S; Pliakos C; Styliadis IH; Parcharidis GE
    Am J Cardiol; 2009 Sep; 104(5):743. PubMed ID: 19699364
    [No Abstract]   [Full Text] [Related]  

  • 6. Aborted sudden cardiac death due to radiofrequency ablation within the coronary sinus and subsequent total occlusion of the circumflex artery.
    Makimoto H; Zhang Q; Tilz RR; Wissner E; Cuneo A; Kuck KH; Ouyang F
    J Cardiovasc Electrophysiol; 2013 Aug; 24(8):929-32. PubMed ID: 23362986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk and Causes of Death in Patients After Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy.
    Veselka J; Zemánek D; Jahnlová D; Krejčí J; Januška J; Dabrowski M; Bartel T; Tomašov P
    Can J Cardiol; 2015 Oct; 31(10):1245-51. PubMed ID: 26095933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intracoronary myocardial contrast echocardiography in a patient with drug refractory hypertrophic obstructive cardiomyopathy revealing extensive myocardium at risk for infarction with alcohol septal ablation.
    Monakier D; Horlick E; Ross J; Woo A; Rakowski H; Schwartz L; Riley MP; Carver JR; Aggarwal K; James EA; Aziz S; Ramsdale DR
    J Invasive Cardiol; 2004 Sep; 16(9):482-4. PubMed ID: 15353829
    [No Abstract]   [Full Text] [Related]  

  • 9. Transcoronary ablation of septal hypertrophy does not alter ICD intervention rates in high risk patients with hypertrophic obstructive cardiomyopathy.
    Lawrenz T; Obergassel L; Lieder F; Leuner C; Strunk-Mueller C; Meyer Zu Vilsendorf D; Beer G; Kuhn H
    Pacing Clin Electrophysiol; 2005 Apr; 28(4):295-300. PubMed ID: 15826262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implantable cardioverter-defibrillator therapy for primary prevention of sudden death after alcohol septal ablation of hypertrophic cardiomyopathy.
    Cuoco FA; Spencer WH; Fernandes VL; Nielsen CD; Nagueh S; Sturdivant JL; Leman RB; Wharton JM; Gold MR
    J Am Coll Cardiol; 2008 Nov; 52(21):1718-23. PubMed ID: 19007692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Septal alcohol ablation in hypertrophic obstructive cardiomyopathy: improving cardiac function by generating a myocardial scar.
    Efthimiadis GK; Mezilis NE; Giannakoulas G; Parcharidis GE
    Eur Heart J; 2007 May; 28(10):1270-1; author reply 1271. PubMed ID: 17463007
    [No Abstract]   [Full Text] [Related]  

  • 12. Survival and sudden cardiac death after septal ablation for hypertrophic obstructive cardiomyopathy.
    Jensen MK; Havndrup O; Hassager C; Helqvist S; Kelbæk H; Jørgensen E; Køber L; Bundgaard H
    Scand Cardiovasc J; 2011 Jun; 45(3):153-60. PubMed ID: 21604920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Alcohol septal ablation and prevention of sudden cardiac death in patients with hypertrophic cardiomyopathy. A case report].
    Ardashev AV; Shavarov AA; Dzhandzhgava AO; Rybachenko MS; Kriuchko MIu
    Kardiologiia; 2009; 49(6):72-9. PubMed ID: 19656099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of surgical septal myectomy and alcohol septal ablation with cardiac magnetic resonance imaging in patients with hypertrophic obstructive cardiomyopathy.
    Valeti US; Nishimura RA; Holmes DR; Araoz PA; Glockner JF; Breen JF; Ommen SR; Gersh BJ; Tajik AJ; Rihal CS; Schaff HV; Maron BJ
    J Am Coll Cardiol; 2007 Jan; 49(3):350-7. PubMed ID: 17239717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgical septal myectomy versus alcohol septal ablation: assessing the status of the controversy in 2014.
    Maron BJ; Nishimura RA
    Circulation; 2014 Oct; 130(18):1617-24. PubMed ID: 25462821
    [No Abstract]   [Full Text] [Related]  

  • 16. Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy.
    Maron BJ; Shen WK; Link MS; Epstein AE; Almquist AK; Daubert JP; Bardy GH; Favale S; Rea RF; Boriani G; Estes NA; Spirito P
    N Engl J Med; 2000 Feb; 342(6):365-73. PubMed ID: 10666426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome of alcohol septal ablation for obstructive hypertrophic cardiomyopathy.
    Sorajja P; Valeti U; Nishimura RA; Ommen SR; Rihal CS; Gersh BJ; Hodge DO; Schaff HV; Holmes DR
    Circulation; 2008 Jul; 118(2):131-9. PubMed ID: 18591440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ambulatory monitoring of aborted sudden cardiac death related to hypertrophic cardiomyopathy.
    Vaglio JC; Sorajja P; Gersh BJ
    Nat Clin Pract Cardiovasc Med; 2005 Dec; 2(12):659-62; quiz following 662. PubMed ID: 16306922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inappropriate therapy from a defibrillator complicating transcoronary ablation of septal hypertrophy in a patient with hypertrophic obstructive cardiomyopathy.
    Shah P; Harris L; Hill A; Schwartz L; Cameron D
    Pacing Clin Electrophysiol; 2004 May; 27(5):677-80. PubMed ID: 15125730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FOLFOX chemotherapy as a cause of ventricular septal rupture after alcohol septal ablation for obstructive hypertrophic cardiomyopathy?
    Liebregts M; Bol GM; Groen JW; Lieuw-a-Fa M; Heijmen RH; ten Berg JM
    Int J Cardiol; 2016 Mar; 207():208-10. PubMed ID: 26803246
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.